CONTACT US FOR FREE SAMPLE !
If You Can Envision It, Then We Can Build It!
Tell Us More About Your Project.
American Cancer Society(ACS) support e-cigarette and nobody expects this will happen and it did happen. It’s reported by San Diego Union-Tribune that ACS suggest people should use e-cigarette if they have much difficulty in quit smoking .The opposition thinks e-cigarette is very harmful .Others think vaping is less risky and harmful. ACS made a statement that smokers should stay away from all tobacco products related and switch from traditional smoking to vaping. Consumers Choice Center said it is great movement on Twitter. People never stop arguring about the risky between traditional tobacco and vaping . However , a report from University of Southern California said e-cigarette may result in non-smoker smoking. Supporters of Vaping think Combustible tobacco products, primarily cigarettes, are the single greatest cause of cancer and kill about 7 million people worldwide each year. In the United States, 98% of all tobacco-related deaths are caused by cigarette smoking. The U.S. tobacco landscape has changed rapidly in recent years, with millions of consumers now using electronic nicotine delivery systems (ENDS), the most prominent of which are electronic cigarettes (e-cigarettes). E-cigarettes contain heated nicotine extracted from tobacco, as well as a variety of flavorings and other additives. The ACS encourages the FDA to regulate all tobacco products, including e-cigarettes, to the full extent of its authority, and to determine the absolute and relative harms of each product. The FDA should assess whether e-cigarettes help to reduce tobacco-related morbidity and mortality, and the impact of marketing of e-cigarettes on consumer perceptions and behavior. Any related regulatory regime should include post-marketing surveillance to monitor the long-term effects of these products and ensure the FDA’s actions have the intended health outcome of significantly reducing disease and death. Furthermore, the FDA should use its authorities to reduce the toxicity, addictiveness and appeal of tobacco products currently on the market. The ACS also applauds the FDA for recognizing its significant role as a science-based agency in helping to address the addictiveness of nicotine in cigarettes. Reducing nicotine in all combustible tobacco products to below addictive levels holds the potential to significantly accelerate reductions in the use of combustible tobacco products, which remain by far the leading preventable cause of cancer and preventable death in the United States.